I now have comprehensive information from multiple textbooks. Here is a thorough synthesis:
Treatment of Infected Wounds
1. Recognizing Infection vs. Colonization
All chronic open wounds are colonized by bacteria, but true infection must be distinguished from mere colonization. Signs of true wound infection include:
- Increased erythema, warmth, and tenderness
- Purulent (pus) drainage
- Swelling, pain, fever (systemic signs)
- Failure to heal despite appropriate care
A bacterial burden >10⁶ colony-forming units/gram of tissue predicts delayed healing and high infection risk. Bacteria can also persist as biofilms — communities protected by a polymeric matrix — which are harder to eradicate.
— Dermatology 2-Volume Set 5e
2. General Principles of Management
Step 1 — Establish the Diagnosis and Identify the Organism
- Obtain wound cultures before starting antibiotics to identify the causative organism and guide antibiotic selection.
- Culture results should direct definitive antibiotic therapy.
Step 2 — Surgical Debridement
- Debride the infected wound to remove devitalized tissue, biofilm, and foreign material.
- For wounds with abscess or fluid collections, drainage (surgical or percutaneous) is required — antibiotics alone are insufficient without source control.
- Infected hematomas require US-guided or open surgical drainage.
- Sutures can be removed to allow drainage of exudate in postoperative infections.
Step 3 — Antibiotic Therapy
- Empiric systemic antibiotics are chosen based on likely pathogens, then adjusted per culture results.
- Deep/severe infections typically require intravenous antibiotics.
— Rockwood and Green's Fractures in Adults 10e; Tintinalli's Emergency Medicine
3. Antibiotic Selection
| Clinical Scenario | First-Line Agent | Alternatives |
|---|
| Typical wound infection (S. aureus) | Cephalexin or Dicloxacillin (oral) | Clindamycin (penicillin allergy) |
| Community/hospital MRSA concern | Doxycycline or TMP-SMX | Vancomycin (IV, severe) |
| Gram-negative / Pseudomonas (e.g., ear) | Ciprofloxacin | — |
| Implant infection (S. aureus predominant) | Vancomycin + Gentamicin (IV) | Tetracycline / Doxycycline (outpatient) |
| No abscess, no systemic toxicity, immunocompetent | Oral first-generation cephalosporin (outpatient) | — |
Indications for inpatient/IV treatment:
- Worsening cellulitis or systemic response (fever, hypotension)
- Purulent drainage or abscess
- Failure to improve after 48 hours of oral antibiotics
- Immunocompromise
— Andrews' Diseases of the Skin; Tintinalli's Emergency Medicine
4. Wound Dressings for Infected/Colonized Wounds
| Dressing Type | Use in Infected Wounds |
|---|
| Gauze (NaCl-impregnated) | Heavily exudating wounds; discourages bacterial overgrowth |
| Alginates | Moderate-to-heavy exudate; hemostatic |
| Silver-containing dressings | Broad-spectrum antimicrobial (incl. MRSA, VRE); releases Ag⁺ ions |
| Hydrocolloids | NOT suitable for infected wounds |
| Hydrogels | Dry wounds with minimal exudate only |
Avoid hydrocolloids in infected wounds — they create a sealed, anaerobic environment that can worsen infection.
5. Topical Antimicrobials
Used when critical colonization delays healing despite appropriate wound care:
- Topical antibiotics: Bacitracin, mupirocin, neomycin, gentamicin, fusidic acid — narrower spectrum, less tissue toxicity, but risk of allergic contact dermatitis (especially neomycin/bacitracin) and resistance. Avoid topical agents that have a systemic counterpart.
- Antiseptics:
- Chlorhexidine — broad spectrum, commonly used
- Povidone-iodine — broad spectrum but cytotoxic at full concentration
- Cadexomer iodine — sustained-release iodine, less cytotoxic, effective against biofilms
- Silver sulfadiazine — broad spectrum including MRSA/VRE; note risk of neutropenia in children
- Hydrogen peroxide — broad spectrum but cytotoxic; limited use
Note: Routine topical antibiotics after skin surgery have not been shown to reduce infection rates vs. petrolatum, and increase risk of allergic contact dermatitis.
— Dermatology 2-Volume Set 5e; Andrews' Diseases of the Skin
6. Special Considerations
- Tetanus status: Chronic or contaminated wounds are a portal for Clostridium tetani — always assess and update tetanus immunization.
- Biofilm: Standard topical antimicrobials may be insufficient; biofilm disruption (debridement, cadexomer iodine, silver) is often needed.
- Bone/implant infections: Stable implants may remain in situ with IV antibiotics + debridement; unstable fixation requires implant removal. Antibiotic-impregnated bone substitutes can deliver high local concentrations.
- Diabetic foot: Wound debridement combined with antibiotics avoids amputation in ~2/3 of patients.
Quick Summary Algorithm
- Culture the wound before antibiotics
- Debride — remove necrotic tissue, drain pus/abscesses
- Antibiotics — empiric (cover S. aureus first), then adjust per sensitivities
- Dress appropriately — silver or alginate for infected/exudating wounds
- Reassess at 48 hours — escalate to IV/inpatient if no improvement
- Check tetanus status
- Address underlying cause (diabetes, venous insufficiency, immunocompromise)